Strong Demand Supports Positive Pharmaceutical Outlook For Japan
Pharma & Healthcare / Japan / Thu 18 Nov, 2021
Key View
- We remain positive on our outlook for Japan's healthcare sector under the leadership of Prime Minister Kishida.
- Pricing environment will weigh on drugmakers’ growth prospects in Japan.
- A slowing economy will further restrict the government’s ability to increase spending on pharmaceuticals.
We remain positive on our outlook for